Immunogenicity and safety of a trivalent inactivated 2010-2011 influenza vaccine in Taiwan infants aged 6-12 months

被引:5
作者
Hwang, Kao-Pin [1 ,6 ]
Hsu, Yu-Lung [1 ]
Hsieh, Tsung-Hsueh [1 ]
Lin, Hsiao-Chuan [1 ]
Yen, Ting-Yu [1 ]
Wei, Hsiu-Mei [1 ]
Lin, Hung-Chih [2 ]
Chen, An-Chyi [3 ]
Chow, Julie Chi [4 ]
Huang, Li-Min [5 ]
机构
[1] China Med Univ Hosp, Dept Pediat, Div Pediat Infect Dis, Taichung, Taiwan
[2] China Med Univ Hosp, Div Neonatol, Dept Pediat, Taichung, Taiwan
[3] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan
[4] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan
[5] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei 10764, Taiwan
[6] China Med Univ, Sch Med, Taichung 404, Taiwan
关键词
Children; Infant; Influenza; Influenza vaccine; Immunogenicity; Safety; CHILDREN; 6; IMMUNIZATION; VIRUS;
D O I
10.1016/j.vaccine.2014.02.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This prospective study aimed to investigate the immune responses and safety of an influenza vaccine in vaccine-naive infants aged 6-12 months, and was conducted from November 2010 to May 2011. Fifty-nine infants aged 6-12 months received two doses of trivalent inactivated influenza vaccine 4 weeks apart. Hemagglutination inhibition titers were measured 4 weeks after the two doses of study vaccine. Based on the assumption that a hemagglutination inhibition titer of 1:40 or greater against the antigen would be protective in adults, two doses of the study vaccine generated a protective immune response of 63.2% against influenza A(H1N1), 82.5% against influenza A(H3N2) and 38.6% against influenza B viruses in infants aged 6-12 months. The geometric mean fold rises against influenza type A and B viruses also met the European Medicines Agency criteria for flu vaccines. The solicited events within 7 days after vaccination were mild in intensity. No deaths or adverse events such as optic neuritis, cranial neuropathy, and brachial neuropathy or Guillain-Barre syndrome were reported. Two doses of inactivated influenza vaccine were well tolerated and induced a protective immune response against influenza in infants aged 6-12 months. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2469 / 2473
页数:5
相关论文
共 21 条
[1]   Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season [J].
Allison, Mandy A. ;
Daley, Matthew F. ;
Crane, Lori A. ;
Barrow, Jennifer ;
Beaty, Brenda L. ;
Allred, Norma ;
Berman, Stephen ;
Kempe, Allison .
JOURNAL OF PEDIATRICS, 2006, 149 (06) :755-762
[2]   IMMUNIZATION WITH KILLED INFLUENZA-VIRUS IN CHILDREN WITH CHRONIC ASTHMA [J].
BELL, TD ;
CHAI, H ;
BERLOW, B ;
DANIELS, G .
CHEST, 1978, 73 (02) :140-145
[3]  
BLACK SC, 2011, AM POETRY REV, V40, P30
[4]   Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects [J].
Couch, Robert B. ;
Winokur, Patricia ;
Brady, Rebecca ;
Belshe, Robert ;
Chen, Wilbur H. ;
Cate, Thomas R. ;
Sigurdardottir, Bryndis ;
Hoeper, Amy ;
Graham, Irene L. ;
Edelman, Robert ;
He, Fenhua ;
Nino, Diane ;
Capellan, Jose ;
Ruben, Frederick L. .
VACCINE, 2007, 25 (44) :7656-7663
[5]   Influenza [J].
Cox, NJ ;
Subbarao, K .
LANCET, 1999, 354 (9186) :1277-1282
[6]   MATERNAL IMMUNIZATION WITH INFLUENZA OR TETANUS TOXOID VACCINE FOR PASSIVE ANTIBODY PROTECTION IN YOUNG INFANTS [J].
ENGLUND, JA ;
MBAWUIKE, IN ;
HAMMILL, H ;
HOLLEMAN, MC ;
BAXTER, BD ;
GLEZEN, WP .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :647-656
[7]   Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers [J].
Englund, Janet A. ;
Walter, Emmanuel B. ;
Gbadebo, Adepeju ;
Monto, Arnold S. ;
Zhu, Yuwei ;
Neuzil, Kathleen M. .
PEDIATRICS, 2006, 118 (03) :E579-E585
[8]   Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants A Randomized Double-Blind Placebo-Controlled Study [J].
Englund, Janet A. ;
Walter, Emmanuel ;
Black, Steven ;
Blatter, Mark ;
Nyberg, Jack ;
Ruben, Frederick L. ;
Decker, Michael D. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (02) :105-110
[9]   SAFETY AND IMMUNOGENICITY OF A PURIFIED HEMAGGLUTININ ANTIGEN IN VERY YOUNG HIGH-RISK CHILDREN [J].
GROOTHUIS, JR ;
LEHR, MV ;
LEVIN, MJ .
VACCINE, 1994, 12 (02) :139-141
[10]   Safety and immunogenicity of trivalent inactivated influenza vaccine in infants [J].
Halasa, Natasha B. ;
Gerber, Michael A. ;
Chen, Qingxia ;
Wright, Peter F. ;
Edwards, Kathryn M. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (10) :1448-1454